BAKER BIOTECH CAPITAL II GP LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BIOTECH CAPITAL II GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BIOTECH CAPITAL II GP LLC. BAKER BIOTECH CAPITAL II GP LLC is a 10% Owner in NEUROGEN CORP ($NRGN) and a Director in NEUROGEN CORP ($NRGN) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN).
Address: 667 MADISON AVENUE NEW YORK 10021 NY
Companies in which BAKER BIOTECH CAPITAL II GP LLC is an Insider
Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BIOTECH CAPITAL II GP LLC: 10% Owner
Holdings: 396,338 shares
Latest Transaction: Apr 14 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROGEN CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BIOTECH CAPITAL II GP LLC: Director, 10% Owner
Holdings: 2,039,196 shares
Latest Transaction: Nov 02 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BIOTECH CAPITAL II GP LLC: Director
Holdings: 264,773 shares
Current Value: $16,095,551
Latest Transaction: Apr 01 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BIOTECH CAPITAL II GP LLC: Director
Holdings: 1,144,755 shares
Latest Transaction: Nov 02 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BIOTECH CAPITAL II GP LLC: 10% Owner
Holdings: 193 shares
Latest Transaction: Apr 22 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of BAKER BIOTECH CAPITAL II GP LLC
Sentiment: All, IBPI, NRGN, SGEN, GEVA, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 395,000 | 43,114,250 | 1,201,000 | |
| Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 268,000 | 29,252,200 | 806,000 | |
| Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 93,000 | 232,500 | 4,967,000 | |
| Apr 18 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 63,000 | 157,500 | 4,874,000 | |
| Apr 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 538,000 | 58,722,700 | 538,000 | |
| Apr 12 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 139,000 | 347,500 | 4,811,000 | |
| Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 31,000 | 77,500 | 4,213,000 |
View all BAKER BIOTECH CAPITAL II GP LLC insider transactions.